C Ray Therapeutics develops healthcare advancements through nuclear medicine. It was founded in 2020.
Full-Life Technologies
Series B in 2024
Full-Life Technologies specializes in developing and commercializing radiopharmaceuticals for cancer therapy. It offers research and development, production, and distribution services within the radiotherapy sector, aiming to enhance patient outcomes through innovative nuclear medicine solutions.
Full-Life Technologies
Debt Financing in 2024
Full-Life Technologies specializes in developing and commercializing radiopharmaceuticals for cancer therapy. It offers research and development, production, and distribution services within the radiotherapy sector, aiming to enhance patient outcomes through innovative nuclear medicine solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.